From Rare Disease to Remarkable Discovery: How Rally Helped Launch a New Path for Pediatric Cancer Research
When traditional funding sources weren’t ready to support this high-risk idea, Rally Foundation for Childhood Cancer Research stepped in. ...
From Seed Funding to a New Leukemia Drug: How Rally Helped Launch 10+ Years of Discovery
Rally Foundation’s early investment in Mark Chiang’s, M.D., Ph.D, lab at the University of Michigan helped generate the preliminary data...
Disrupting Cancer at Its Core: Rally’s Early Investment in Life-Saving Discovery
In 2018, Muxiang Zhou, MD, at Emory University School of Medicine received early research funding from Rally Foundation for Childhood...
June Is National Cancer Survivors Month and Infertility Awareness Month
June is National Cancer Survivors Month, a time when Rally Foundation honors the strength and resilience of survivors of childhood cancer....
The Power of Starting Early: How One Grant Sparked Lifesaving Leukemia Discoveries
In 2015, Jessica Heath, M.D., at Duke University School of Medicine received early research funding from Rally Foundation for Childhood...
What Are the Most Common Childhood Cancers?
It’s no secret that adults get cancer. But children get cancer, too -- and it’s more common than you might think. Worldwide, 300,000 kids...
What is Rhabdomyosarcoma?
Rhabdomyosarcoma (RMS) is a type of soft tissue cancer that most commonly affects children and adolescents. It’s often found in skeletal...
What is Ewing Sarcoma?
Ewing Sarcoma Defined Ewing sarcoma is a cancerous bone tumor that affects children, adolescent and young adults—usually developing during...
May Is Brain Tumor Awareness Month
May Is Brain Tumor Awareness Month May is recognized as Brain Tumor Awareness Month, a time dedicated to shining a light on one of the...
What Is Osteosarcoma?
Osteosarcoma is the most common type of bone cancer in children and adolescents. The tumor often originates in the long bones of the body,...
From Rare Disease to Remarkable Discovery: How Rally Helped Launch a New Path for Pediatric Cancer Research
When traditional funding sources weren’t ready to support this high-risk idea, Rally Foundation for Childhood Cancer Research stepped in. With Rally Foundation’s early funding, Dr. Mark Hatley and his team at St. Jude uncovered a surprising discovery in children with DICER1 cancer predisposition syndrome: A type of white blood cell called a neutrophil may actually help tumors form by releasing harmful web-like structures called neutrophil extracellular traps. The team...
From Seed Funding to a New Leukemia Drug: How Rally Helped Launch 10+ Years of Discovery
Rally Foundation’s early investment in Mark Chiang’s, M.D., Ph.D, lab at the University of Michigan helped generate the preliminary data needed to secure more than $7 million in funding from the National Institutes of Health and over a decade of continuous federal support. Today, Dr. Chiang’s research is exploring a groundbreaking oral drug, RGT-61159, designed to stop cancer-driving proteins before they even form. This work could open the door to safer, more targeted treatments for children...
Disrupting Cancer at Its Core: Rally’s Early Investment in Life-Saving Discovery
In 2018, Muxiang Zhou, MD, at Emory University School of Medicine received early research funding from Rally Foundation for Childhood Cancer Research. That support helped launch discoveries that are bringing new hope to children with hard-to-treat cancers. Dr. Zhou studies childhood cancer and searches for biomarkers, special clues in the body that show how cancer is growing. His work focuses on creating new medicines for kids with neuroblastoma and acute myeloid leukemia, especially when...
June Is National Cancer Survivors Month and Infertility Awareness Month
June is National Cancer Survivors Month, a time when Rally Foundation honors the strength and resilience of survivors of childhood cancer. It is also Infertility Awareness Month, bringing attention to one of the many long-term side effects survivors may face after treatment. Today, more children are surviving cancer because of advancements in research. But survivorship often comes with lifelong challenges, including heart and lung disease, learning disabilities, secondary cancers and...
The Power of Starting Early: How One Grant Sparked Lifesaving Leukemia Discoveries
In 2015, Jessica Heath, M.D., at Duke University School of Medicine received early research funding from Rally Foundation for Childhood Cancer Research. That first grant helped launch her career and gave her the chance to study how leukemia begins. Dr. Heath focused on a protein called CRM1. This protein normally helps cells work the right way. But in leukemia, CRM1 can help cancer grow. Rally’s early support gave her the freedom to ask big questions about how leukemia starts and spreads. ...
What Are the Most Common Childhood Cancers?
It’s no secret that adults get cancer. But children get cancer, too -- and it’s more common than you might think. Worldwide, 300,000 kids are diagnosed with cancer every year. And in the U.S., 1 in 285 children will be diagnosed with cancer before they turn 20. There are many types of childhood cancers. Some cancers are more common in children than adults, and there are some cancers that only children get. Here’s a look at some of the most common childhood cancers. Leukemia The most common...